טוען...
Plasma amyloid β 42/40 ratios as biomarkers for amyloid β cerebral deposition in cognitively normal individuals
INTRODUCTION: Plasma amyloid β (Aβ) peptides have been previously studied as candidate biomarkers to increase recruitment efficiency in secondary prevention clinical trials for Alzheimer's disease. METHODS: Free and total Aβ42/40 plasma ratios (FP42/40 and TP42/40, respectively) were determined...
שמור ב:
| הוצא לאור ב: | Alzheimers Dement (Amst) |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5602863/ https://ncbi.nlm.nih.gov/pubmed/28948206 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.dadm.2017.07.004 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|